Status:
RECRUITING
Safety of PET MPI Using the CRCHUM N-13 Ammonia
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
N-13 Ammonia Safety
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Positron emission tomography (PET) myocardial perfusion imaging (MPI) is an examination that helps to assess the function and perfusion of the heart. Completion of this examination requires the inject...
Eligibility Criteria
Inclusion
- Adult patient being referred for clinically indicated positron emission tomography myocardial perfusion imaging at the Centre hospitalier de l'Université de Montréal
Exclusion
- Pregnant women
- Claustrophobic patient unable to undergo the examination
- Breastfeeding women unwilling to temporarily stop breastfeeding
- Patient with contra-indication to: dipyridamole, aminophylline, dobutamine or exercise stress test (depending on the method of cardiovascular stress test chosen)
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT03275584
Start Date
January 30 2018
End Date
January 1 2028
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'université de Montréal
Montreal, Quebec, Canada, H2X 0C1